Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Extrapulmonary Neuroendocrine Carcinoma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Endocrine Neoplasm
Neuroendocrine Neoplasm
Neuroendocrine Carcinoma
Extrapulmonary Neuroendocrine Carcinoma

Subtype

Extrapulmonary Neuroendocrine Carcinoma

CI-CAN-00002658Explore in graph →

104 active trials6 approved drugs22 evidence items

NCIt: C191977

Overview
Statistics
Survival
Genomics
Variants & evidence22
Drugs9
Trials315
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

315 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 104
Recruiting: 46
Ph III recruiting: 1
Growth YoY: —
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 41.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (50)

StatusAll Active (any)Completed 106 Recruiting 57 Active Not Recruiting 50 Terminated 38 Unknown 22 Not Yet Recruiting 18 Withdrawn 13 Approved For Marketing 4 Enrolling By Invitation 3 No Longer Available 2 Suspended 1 Available 1

PhaseAll Early Phase 1 2 N/A 25 Phase 1 98 Phase 2 163 Phase 3 13 Phase 4 3

No study matches these filters